Keyphrases
Coronary Artery Disease
100%
Chronic Heart Failure
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Spironolactone
100%
Aldosterone
71%
Harmful Effects
42%
Ventricular Arrhythmia
28%
Norepinephrine Uptake
28%
Blood Pressure
14%
Echocardiographic
14%
Placebo
14%
Left Ventricular Systolic Function
14%
Angiotensin II (Ang II)
14%
Left Ventricular Function
14%
Diuretics
14%
Loop Diuretics
14%
Plasma Renin Activity
14%
New York Heart Association
14%
Magnesium
14%
Congestive Heart Failure
14%
Plasma Aldosterone Concentration
14%
Aldosterone Antagonists
14%
24-h Urinary Sodium Excretion
14%
Urinary Sodium
14%
Anesthetized Rats
14%
Plasma Magnesium
14%
Metaiodobenzylguanidine Scintigraphy
14%
Cardiac Sympathetic Activity
14%
Blood Plasma
14%
Ambulatory Electrocardiographic Monitoring
14%
Plasma Potassium
14%
Fractional Excretion of Magnesium
14%
Sodium-to-potassium Ratio
14%
Medicine and Dentistry
ACE Inhibitor
100%
Coronary Artery Disease
100%
Congestive Heart Failure
100%
Spironolactone
100%
Aldosterone
85%
Urinary System
42%
Magnesium
28%
Heart Ventricle Arrhythmia
28%
Noradrenalin Uptake
28%
Blood Pressure
14%
Placebo
14%
Systolic Function
14%
Angiotensin II
14%
Renin
14%
Diastolic Function
14%
Loop Diuretic Agent
14%
Aldosterone Antagonist
14%
Magnesium Excretion
14%
Sodium Excretion
14%
Scintigraphy
14%
Iodine 123
14%
(3 Iodobenzyl)guanidine
14%
Holter Monitoring
14%
Diuretics
14%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
100%
Enzyme Inhibitor
100%
Spironolactone
100%
Aldosterone
85%
Cardiac Dysrhythmia
28%
Sodium Urine Level
28%
Noradrenalin Uptake
28%
Blood Pressure
14%
Animal Experiment
14%
Magnesium Blood Level
14%
Plasma Renin Activity
14%
Aldosterone Blood Level
14%
Iobenguane
14%
Iodine-123
14%
Magnesium Urine Level
14%
Magnesium Excretion
14%
Blood Plasma
14%
Angiotensin
14%
Electrocardiography
14%